199 related articles for article (PubMed ID: 31899683)
21. Isolates of Alpinia officinarum Hance as COX-2 inhibitors: Evidence from anti-inflammatory, antioxidant and molecular docking studies.
Honmore VS; Kandhare AD; Kadam PP; Khedkar VM; Sarkar D; Bodhankar SL; Zanwar AA; Rojatkar SR; Natu AD
Int Immunopharmacol; 2016 Apr; 33():8-17. PubMed ID: 26849772
[TBL] [Abstract][Full Text] [Related]
22. Anti-neoplastic activity of two flavone isomers derived from Gnaphalium elegans and Achyrocline bogotensis.
Thomas CM; Wood RC; Wyatt JE; Pendleton MH; Torrenegra RD; Rodriguez OE; Harirforoosh S; Ballester M; Lightner J; Krishnan K; Ramsauer VP
PLoS One; 2012; 7(6):e39806. PubMed ID: 22768128
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
24. 2'-Hydroxy flavanone derivatives as an inhibitors of pro-inflammatory mediators: Experimental and molecular docking studies.
Patel NK; Bairwa K; Gangwal R; Jaiswal G; Jachak SM; Sangamwar AT; Bhutani KK
Bioorg Med Chem Lett; 2015 May; 25(9):1952-5. PubMed ID: 25824662
[TBL] [Abstract][Full Text] [Related]
25. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
[TBL] [Abstract][Full Text] [Related]
26. Indole Derivatives as Cyclooxygenase Inhibitors: Synthesis, Biological Evaluation and Docking Studies.
Bhat MA; Al-Omar MA; Raish M; Ansari MA; Abuelizz HA; Bakheit AH; Naglah AM
Molecules; 2018 May; 23(6):. PubMed ID: 29882911
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
Takao K; U S; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, computational assay and anti-inflammatory activity of thiosemicarbazone derivatives: Highly potent and efficacious for COX inhibitors.
Saeed K; Rafiq M; Khalid M; Hussain A; Siddique F; Hanif M; Hussain S; Mahmood K; Ameer N; Ahmed MM; Ali Khan M; Yaqub M; Jabeen M
Int Immunopharmacol; 2024 Jan; 126():111259. PubMed ID: 37992446
[TBL] [Abstract][Full Text] [Related]
29. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
[TBL] [Abstract][Full Text] [Related]
30. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
[TBL] [Abstract][Full Text] [Related]
31. Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluation.
Sahin Z; Özhan Y; Sipahi H; Biltekin SN; Yurttaş L; Berk B; Demirayak Ş
Z Naturforsch C J Biosci; 2022 Jul; 77(7-8):279-285. PubMed ID: 34902233
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
Lamie PF; Philoppes JN; Rárová L
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives.
Abdel-Sayed MA; Bayomi SM; El-Sherbeny MA; Abdel-Aziz NI; ElTahir KE; Shehatou GS; Abdel-Aziz AA
Bioorg Med Chem; 2016 May; 24(9):2032-42. PubMed ID: 27025563
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
35. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
Bakr RB; Ghoneim AA; Azouz AA
Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
[TBL] [Abstract][Full Text] [Related]
36. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and SAR study of novel flavone 1,2,4-oxadiazole derivatives with anti-inflammatory activities for the treatment of Parkinson's disease.
Shen ZB; Meng HW; Meng XS; Lv ZK; Fang MY; Zhang LL; Lv ZL; Li MS; Liu AK; Han JH; Li QS; Duan YJ
Eur J Med Chem; 2023 Jul; 255():115417. PubMed ID: 37137246
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
39. First report of antioxidative
Antony T; Chakraborty K
Nat Prod Res; 2020 Dec; 34(24):3470-3482. PubMed ID: 30887827
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments.
Dennis Bilavendran J; Manikandan A; Thangarasu P; Sivakumar K
Bioorg Chem; 2020 Jan; 94():103484. PubMed ID: 31796215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
